Gabriel Leung insider trades: NovoCure (NVCR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gabriel reports to the SEC
Open-market buys and sales
43 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | NVCR | ↓ Sell | 2,945 | $15.77 | $46K | Direct | Jun 3, 2026 (1d) |
| Jun 3, 2025 | NVCR | ↓ Sell | 999 | $17.31 | $17K | Direct | Jun 4, 2025 (1d) |
| Jun 4, 2024 | NVCR | ↓ Sell | 964 | $23.89 | $23K | Direct | Jun 6, 2024 (2d) |
| Aug 5, 2021 | NVCR | ↓ Sell10b5-1 | 1,000 | $152.50 | $153K | Direct | Aug 6, 2021 (1d) |
| Jul 6, 2021 | NVCR | ↓ Sell10b5-1 | 1,000 | $183.54 | $184K | Direct | Jul 8, 2021 (2d) |
| Jun 7, 2021 | NVCR | ↓ Sell10b5-1 | 1,000 | $204.55 | $205K | Direct | Jun 8, 2021 (1d) |
| May 5, 2021 | NVCR | ↓ Sell10b5-1 | 1,000 | $199.67 | $200K | Direct | May 6, 2021 (1d) |
| Apr 13, 2021 | NVCR | ↓ Sell10b5-1 | 6,000 | $198.84 | $1.2M | Direct | Apr 15, 2021 (2d) |
| Sep 15, 2020 | NVCR | ↓ Sell10b5-1 | 19,565 | $97.44 | $1.9M | Direct | Sep 16, 2020 (1d) |
| Sep 10, 2020 | NVCR | ↓ Sell10b5-1 | 19,114 | $87.80 | $1.7M | Direct | Sep 11, 2020 (1d) |
| Sep 2, 2020 | NVCR | ↓ Sell10b5-1 | 100 | $85.00 | $9K | Direct | Sep 4, 2020 (2d) |
| Aug 25, 2020 | NVCR | ↓ Sell10b5-1 | 7,112 | $80.13 | $570K | Direct | Aug 27, 2020 (2d) |
| Jul 30, 2020 | NVCR | ↓ Sell10b5-1 | 7,112 | $75.00 | $533K | Direct | Aug 3, 2020 (4d) |
| Jul 22, 2020 | NVCR | ↓ Sell10b5-1 | 10,000 | $66.93 | $669K | Direct | Jul 23, 2020 (1d) |
| Nov 25, 2019 | NVCR | ↓ Sell10b5-1 | 20,000 | $95.00 | $1.9M | Direct | Nov 26, 2019 (1d) |
| Nov 20, 2019 | NVCR | ↓ Sell10b5-1 | 20,000 | $90.00 | $1.8M | Direct | Nov 22, 2019 (2d) |
| Nov 18, 2019 | NVCR | ↓ Sell10b5-1 | 20,000 | $84.12 | $1.7M | Direct | Nov 19, 2019 (1d) |
| Nov 11, 2019 | NVCR | ↓ Sell10b5-1 | 5,000 | $79.57 | $398K | Direct | Nov 13, 2019 (2d) |
| Oct 10, 2019 | NVCR | ↓ Sell10b5-1 | 5,000 | $72.28 | $361K | Direct | Oct 15, 2019 (5d) |
| Sep 10, 2019 | NVCR | ↓ Sell10b5-1 | 5,000 | $76.63 | $383K | Direct | Sep 12, 2019 (2d) |
| Aug 12, 2019 | NVCR | ↓ Sell10b5-1 | 5,000 | $86.45 | $432K | Direct | Aug 14, 2019 (2d) |
| Jul 10, 2019 | NVCR | ↓ Sell | 5,000 | $64.83 | $324K | Direct | Jul 12, 2019 (2d) |
| Jun 19, 2019 | NVCR | ↓ Sell10b5-1 | 25,000 | $60.02 | $1.5M | Direct | Jun 21, 2019 (2d) |
| Jun 10, 2019 | NVCR | ↓ Sell10b5-1 | 5,000 | $55.05 | $275K | Direct | Jun 12, 2019 (2d) |
| May 10, 2019 | NVCR | ↓ Sell | 5,000 | $49.79 | $249K | Direct | May 14, 2019 (4d) |
| Apr 10, 2019 | NVCR | ↓ Sell | 5,000 | $45.95 | $230K | Direct | Apr 12, 2019 (2d) |
| Mar 11, 2019 | NVCR | ↓ Sell | 5,000 | $48.31 | $242K | Direct | Mar 12, 2019 (1d) |
| Mar 1, 2019 | NVCR | ↓ Sell | 25,000 | $55.01 | $1.4M | Direct | Mar 4, 2019 (3d) |
| Feb 11, 2019 | NVCR | ↓ Sell10b5-1 | 5,000 | $49.59 | $248K | Direct | Feb 13, 2019 (2d) |
| Jan 25, 2019 | NVCR | ↓ Sell10b5-1 | 20,000 | $50.00 | $1.0M | Direct | Jan 28, 2019 (3d) |
| Jan 16, 2019 | NVCR | ↓ Sell | 20,000 | $45.00 | $900K | Direct | Jan 18, 2019 (2d) |
| Jan 10, 2019 | NVCR | ↓ Sell10b5-1 | 5,000 | $39.91 | $200K | Direct | Jan 14, 2019 (4d) |
| Jan 9, 2019 | NVCR | ↓ Sell10b5-1 | 20,000 | $40.00 | $800K | Direct | Jan 11, 2019 (2d) |
| Dec 10, 2018 | NVCR | ↓ Sell10b5-1 | 5,000 | $33.49 | $167K | Direct | Dec 12, 2018 (2d) |
| May 16, 2018 | NVCR | ↓ Sell | 80,000 | $28.82 | $2.3M | Direct | May 17, 2018 (1d) |
| Jun 15, 2012 | DCTH | ↑ Buy | 7,500 | $1.57 | $12K | Direct | Jun 18, 2012 (3d) |
| Dec 7, 2011 | AMRI | ↑ Buy | 8,000 | $2.40 | $19K | Direct | Dec 7, 2011 (0d) |
| Mar 1, 2010 | OSIP | ↓ Sell | 43,233 | $55.37 | $2.4M | Direct | Mar 3, 2010 (2d) |
| Jul 31, 2008 | OSIP | ↓ Sell | 15,000 | $52.96 | $794K | Direct | Aug 1, 2008 (1d) |
| Jul 22, 2008 | OSIP | ↓ Sell | 9,941 | $50.03 | $497K | Direct | Jul 24, 2008 (2d) |
| Jul 21, 2008 | OSIP | ↓ Sell | 59 | $50.00 | $3K | Direct | Jul 22, 2008 (1d) |
| Jul 15, 2008 | OSIP | ↓ Sell | 5,000 | $47.50 | $238K | Direct | Jul 17, 2008 (2d) |
| Jul 10, 2008 | OSIP | ↓ Sell | 5,000 | $45.00 | $225K | Direct | Jul 11, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NVCR insiders
Open-market trades in the last 12 months
About Gabriel Leung's insider trades
Gabriel Leung is an insider at NovoCure (NVCR). Since Jul 10, 2008, Gabriel has reported 2 open-market purchases worth $31K and 41 sales worth $28.3M on SEC Form 4. In the last 12 months: 1 sale ($46K).
25 sales (65% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (39 filings), grants and awards (32 filings), shares withheld for taxes (8 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.